Hovione has over 50 years of experience in the development and compliant manufacture of Active Pharmaceutical Ingredients and Drug Product Intermediates. With four FDA inspected sites, USA, China, Ireland and Portugal, Hovione offers branded pharmaceutical customers services for the development and compliant manufacture of innovative new drugs including highly potent compounds. For generic pharmaceutical customers the company offers niche generic API products. Hovione also offers all customers proprietary product development and licensing opportunities for drug products. Hovione is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.
Hovione is a company with a culture based on innovation, quality and delivery.
Hovione’s culture remains true to the values established by Ivan Villax from the very beginning. He was someone who passionately believed in the importance of the Company’s values, its integrity, serving customers well, scientific rigor and team work. The same principles define how we conduct business today and run deep throughout the organization. We remain fully committed to solving complex problems and delivering solutions that are highly valued by our customers. These themes have been a constant for more than 50 years and no one at Hovione wishes to see them change.
To passionately turn any challenge into a solution by collaborating with our partners to create great medicines.
To become the #1 innovative, integrated pharmaceutical solution provider to the global pharmaceutical industry by 2028.